These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21953412)

  • 1. Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn.
    Reinholdt LG; Ding Y; Gilbert GJ; Czechanski A; Solzak JP; Roper RJ; Johnson MT; Donahue LR; Lutz C; Davisson MT
    Mamm Genome; 2011 Dec; 22(11-12):685-91. PubMed ID: 21953412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ts65Dn -- localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome.
    Akeson EC; Lambert JP; Narayanswami S; Gardiner K; Bechtel LJ; Davisson MT
    Cytogenet Cell Genet; 2001; 93(3-4):270-6. PubMed ID: 11528125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome.
    Duchon A; Raveau M; Chevalier C; Nalesso V; Sharp AJ; Herault Y
    Mamm Genome; 2011 Dec; 22(11-12):674-84. PubMed ID: 21953411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Mmu17 Non-Hsa21 Orthologous Genes in the Ts65Dn Mouse Model of Down Syndrome: The Gold Standard Refuted.
    Guedj F; Kane E; Bishop LA; Pennings JLA; Herault Y; Bianchi DW
    Biol Psychiatry; 2023 Jul; 94(1):84-97. PubMed ID: 37074246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pattern of congenital heart defects arising from reduced Tbx5 expression is altered in a Down syndrome mouse model.
    Polk RC; Gergics P; Steimle JD; Li H; Moskowitz IP; Camper SA; Reeves RH
    BMC Dev Biol; 2015 Jul; 15():30. PubMed ID: 26208718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes.
    Vacík T; Ort M; Gregorová S; Strnad P; Blatny R; Conte N; Bradley A; Bures J; Forejt J
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4500-5. PubMed ID: 15755806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinatal loss of Ts65Dn Down syndrome mice.
    Roper RJ; St John HK; Philip J; Lawler A; Reeves RH
    Genetics; 2006 Jan; 172(1):437-43. PubMed ID: 16172497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.
    Kirsammer G; Jilani S; Liu H; Davis E; Gurbuxani S; Le Beau MM; Crispino JD
    Blood; 2008 Jan; 111(2):767-75. PubMed ID: 17901249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome.
    Richtsmeier JT; Zumwalt A; Carlson EJ; Epstein CJ; Reeves RH
    Am J Med Genet; 2002 Feb; 107(4):317-24. PubMed ID: 11840489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of trisomy on brain shape and volume in related aneuploid mouse models.
    Aldridge K; Reeves RH; Olson LE; Richtsmeier JT
    Am J Med Genet A; 2007 May; 143A(10):1060-70. PubMed ID: 17431903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes.
    Olson LE; Roper RJ; Baxter LL; Carlson EJ; Epstein CJ; Reeves RH
    Dev Dyn; 2004 Jul; 230(3):581-9. PubMed ID: 15188443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
    Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
    Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models of Down syndrome: gene content and consequences.
    Gupta M; Dhanasekaran AR; Gardiner KJ
    Mamm Genome; 2016 Dec; 27(11-12):538-555. PubMed ID: 27538963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postnatal lethality and cardiac anomalies in the Ts65Dn Down syndrome mouse model.
    Moore CS
    Mamm Genome; 2006 Oct; 17(10):1005-12. PubMed ID: 17019652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segmental trisomy as a mouse model for Down syndrome.
    Davisson MT; Schmidt C; Reeves RH; Irving NG; Akeson EC; Harris BS; Bronson RT
    Prog Clin Biol Res; 1993; 384():117-33. PubMed ID: 8115398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel insights from fetal and placental phenotyping in 3 mouse models of Down syndrome.
    Adams AD; Hoffmann V; Koehly L; Guedj F; Bianchi DW
    Am J Obstet Gynecol; 2021 Sep; 225(3):296.e1-296.e13. PubMed ID: 33766516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetrance of Congenital Heart Disease in a Mouse Model of Down Syndrome Depends on a Trisomic Potentiator of a Disomic Modifier.
    Li H; Edie S; Klinedinst D; Jeong JS; Blackshaw S; Maslen CL; Reeves RH
    Genetics; 2016 Jun; 203(2):763-70. PubMed ID: 27029737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome.
    Blazek JD; Billingsley CN; Newbauer A; Roper RJ
    Dev Dyn; 2010 Jun; 239(6):1645-53. PubMed ID: 20503361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased male reproductive success in Ts65Dn "Down syndrome" mice.
    Moore CS; Hawkins C; Franca A; Lawler A; Devenney B; Das I; Reeves RH
    Mamm Genome; 2010 Dec; 21(11-12):543-9. PubMed ID: 21110029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
    Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
    Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.